July 2026– date –
-
eBioHippo Publishes Beginner’s Guide to AAV Gene Delivery: Detailing HEK293T and Baculovirus Expression Systems, Discussing Challenges
eBioHippo USA Overview eBioHippo has released a comprehensive beginner's guide to AAV gene delivery, covering key production methods like HEK293T cell triple transfection and baculovirus/Sf9 insect cell systems for scalable manufacturing... -
Thermo Fisher Scientific Explains How PAT Enables Real-Time Quality Control in Pharmaceutical Manufacturing, With AI Transforming Data into Actionable Insights
Thermo Fisher Scientific (Behind the Bench) USA Overview Thermo Fisher Scientific elucidates how Process Analytical Technology (PAT) facilitates real-time quality control across diverse pharmaceutical modalities, including biologics, mRN... -
ArXiv Paper Unveils ‘Agentic Self-Driving Lab’ with LLMs and Bayesian Optimization to Accelerate Antibody Bioprocess, Drastically Reducing Experimental Costs and Timelines
ArXiv (Preprint server) USA Overview A paper published on ArXiv proposes an innovative 'agentic self-driving lab' concept, combining large language models (LLMs) and Bayesian optimization. Aimed at accelerating scientific discovery, incl... -
US Federal Regulators Approve Cultivated Chicken Sales, But Louisiana May Ban It at State Level, Creating Regional Regulatory Hurdles for Cultivated Meat Market
KTALnews.com (via Yahoo News) USA Overview U.S. federal regulators have approved the sale of cultivated chicken, marking a significant advancement for cultivated meat technology. However, state-level policies, such as those under conside... -
Lonza Accelerates DNA-to-IND Programs with New GS Ori‑Go™ Vector Technology: Delivers Tox Material in 2 Months, IND-Ready in as Fast as 6 Months
Lonza Press Release Switzerland Overview Lonza announced the enhancement of its preclinical development services, featuring the new GS Ori‑Go™ vector technology, to significantly accelerate DNA-to-IND (Investigational New Drug) programs.... -
Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology, Bolstering CNS Therapeutic Delivery Capabilities
Lonza Press Release Switzerland Overview Lonza has acquired the rights to Nona Biosciences' Transferrin Receptor 1 (TfR1) blood-brain barrier (BBB) technology, expanding its strategic collaboration with Nona. This acquisition aims to sig... -
BioPharma APAC Discusses AI Implementation in GMP Facilities and Audit Trail Imperatives: Singapore Automates Digital Twin for Fault Detection
BioPharma APAC Singapore Overview BioPharma APAC examines the current state and challenges of AI implementation in GMP facilities, showcasing applications like predictive maintenance, machine vision QC, and AI-assisted investigations. Th... -
CDMO World Releases Validation Guide for Machine Learning in Bioreactor Optimization, Emphasizing Real-Time Control and Data Governance
CDMO World USA Overview CDMO World has published a validation guide analyzing the operational benefits and data integrity risks of applying machine learning (ML) to bioreactor optimization in commercial fermentation processes. The guide ... -
Chivanta Analysis: Allogeneic CAR-T Surpasses Autologous in Scalable Manufacturing and Immediate Availability, Spotlighting Fate Therapeutics’ iPSC Platform
Chivanta USA Overview Chivanta's analysis indicates allogeneic CAR-T therapies hold significant advantages over autologous CAR-T, particularly in scalable manufacturing, immediate availability, and product consistency. Companies like All... -
Drug Discovery News Analyzes Viral Vector Manufacturing Scale-Up Challenges for Gene Therapies, Highlighting AAV Production Bottlenecks
Drug Discovery News USA Overview Drug Discovery News focuses on the significant scale-up challenges in viral vector manufacturing for gene therapies, particularly emphasizing bottlenecks in adeno-associated virus (AAV) production. The ar...
